Literature DB >> 31883822

Dopamine Evokes a Trace Amine Receptor-dependent Inward Current that is Regulated by AMP Kinase in Substantia Nigra Dopamine Neurons.

Wei Yang1, Adam C Munhall2, Steven W Johnson3.   

Abstract

We reported recently that activators of AMP-activated protein kinase (AMPK) slow the rundown of current evoked by the D2 autoreceptor agonist quinpirole in rat substantia nigra compacta (SNC) dopamine neurons. The present study examined the effect of AMPK on current generated by dopamine, which unlike quinpirole, is a substrate for the dopamine transporter (DAT). Using whole-cell patch-clamp, we constructed current-voltage (I-V) plots while superfusing brain slices with dopamine (100 μM) for 25 min. Two minutes after starting superfusion, dopamine evoked a peak current with an average slope conductance of 0.97 nS and an estimated reversal potential (Erev) of -113 mV, which is near that expected for K+. But after 10 min of superfusion, dopamine-evoked currents had shifted to more depolarized values with a slope conductance of 0.64 nS and an Erev of -83 mV. This inward shift in current was completely blocked by the DAT inhibitor GBR12935. However, an AMPK blocking agent (dorsomorphin) permitted the emergence of inward current despite the continued presence of the DAT inhibitor. When D2 autoreceptors were blocked by sulpiride, I-V plots showed that dopamine evoked an inward current with an estimated slope conductance of 0.45 nS with an Erev of -57 mV. Moreover, this inward current was completely blocked by the trace amine-associated receptor 1 (TAAR1) antagonist EPPTB. These results suggest that dopamine activates a TAAR1-dependent non-selective cation current that is regulated by AMPK.
Copyright © 2019 IBRO. Published by Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  AMP kinase; brain slice; dopamine; dopamine transporter; patch-clamp; trace amine

Year:  2019        PMID: 31883822      PMCID: PMC6997047          DOI: 10.1016/j.neuroscience.2019.11.044

Source DB:  PubMed          Journal:  Neuroscience        ISSN: 0306-4522            Impact factor:   3.590


  70 in total

1.  Neurochemical characterization of pathways expressing plasma membrane monoamine transporter in the rat brain.

Authors:  V Vialou; L Balasse; S Dumas; B Giros; S Gautron
Journal:  Neuroscience       Date:  2006-11-15       Impact factor: 3.590

2.  Taar1-mediated modulation of presynaptic dopaminergic neurotransmission: role of D2 dopamine autoreceptors.

Authors:  D Leo; L Mus; S Espinoza; M C Hoener; T D Sotnikova; R R Gainetdinov
Journal:  Neuropharmacology       Date:  2014-02-22       Impact factor: 5.250

3.  Drugs abused by humans preferentially increase synaptic dopamine concentrations in the mesolimbic system of freely moving rats.

Authors:  G Di Chiara; A Imperato
Journal:  Proc Natl Acad Sci U S A       Date:  1988-07       Impact factor: 11.205

Review 4.  The dopamine-containing neuron: maestro or simple musician in the orchestra of addiction?

Authors:  Antonello Bonci; Giorgio Bernardi; Pernilla Grillner; Nicola B Mercuri
Journal:  Trends Pharmacol Sci       Date:  2003-04       Impact factor: 14.819

5.  Brain-specific overexpression of trace amine-associated receptor 1 alters monoaminergic neurotransmission and decreases sensitivity to amphetamine.

Authors:  Florent G Revel; Claas A Meyer; Amyaouch Bradaia; Karine Jeanneau; Eleonora Calcagno; Cédric B André; Markus Haenggi; Marie-Thérèse Miss; Guido Galley; Roger D Norcross; Roberto W Invernizzi; Joseph G Wettstein; Jean-Luc Moreau; Marius C Hoener
Journal:  Neuropsychopharmacology       Date:  2012-07-04       Impact factor: 7.853

6.  Rhesus monkey trace amine-associated receptor 1 signaling: enhancement by monoamine transporters and attenuation by the D2 autoreceptor in vitro.

Authors:  Zhihua Xie; Susan V Westmoreland; Mary E Bahn; Guo-Lin Chen; Hong Yang; Eric J Vallender; Wei-Dong Yao; Bertha K Madras; Gregory M Miller
Journal:  J Pharmacol Exp Ther       Date:  2007-01-18       Impact factor: 4.030

7.  The selective antagonist EPPTB reveals TAAR1-mediated regulatory mechanisms in dopaminergic neurons of the mesolimbic system.

Authors:  Amyaouch Bradaia; Gerhard Trube; Henri Stalder; Roger D Norcross; Laurence Ozmen; Joseph G Wettstein; Audrée Pinard; Danièle Buchy; Martin Gassmann; Marius C Hoener; Bernhard Bettler
Journal:  Proc Natl Acad Sci U S A       Date:  2009-11-05       Impact factor: 11.205

8.  The organic cation transporter-3 is a pivotal modulator of neurodegeneration in the nigrostriatal dopaminergic pathway.

Authors:  Mei Cui; Radha Aras; Whitney V Christian; Phillip M Rappold; Mamata Hatwar; Joseph Panza; Vernice Jackson-Lewis; Jonathan A Javitch; Nazzareno Ballatori; Serge Przedborski; Kim Tieu
Journal:  Proc Natl Acad Sci U S A       Date:  2009-04-29       Impact factor: 11.205

9.  AMP is a true physiological regulator of AMP-activated protein kinase by both allosteric activation and enhancing net phosphorylation.

Authors:  Graeme J Gowans; Simon A Hawley; Fiona A Ross; D Grahame Hardie
Journal:  Cell Metab       Date:  2013-10-01       Impact factor: 27.287

10.  An unsuspected role for organic cation transporter 3 in the actions of amphetamine.

Authors:  Felix P Mayer; Diethart Schmid; W Anthony Owens; Georgianna G Gould; Mia Apuschkin; Oliver Kudlacek; Isabella Salzer; Stefan Boehm; Peter Chiba; Piper H Williams; Hsiao-Huei Wu; Ulrik Gether; Wouter Koek; Lynette C Daws; Harald H Sitte
Journal:  Neuropsychopharmacology       Date:  2018-04-06       Impact factor: 8.294

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.